Biotechnology
Medical
Biopharmaceutical

PTC Therapeutics

$39.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (0.20%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PTCT and other stocks, options, ETFs, and crypto commission-free!

About

PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. Read More It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Employees
517
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
2.31B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
951.83K
High Today
$40.61
Low Today
$39.02
Open Price
$39.74
Volume
170.80K
52 Week High
$52.95
52 Week Low
$27.53

Collections

Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Therapy
2013 IPO

News

Seeking AlphaMay 10

PTC Therapeutics inks strategic deal with MRI Interventions

PTC Therapeutics (NASDAQ:PTCT) and MRI Interventions (OTCQB:MRIC) have announced a strategic equity investment, with PTC purchasing $4M in shares of MRI common stock.

26
Yahoo FinanceMay 9

PTC Therapeutics and MRI Interventions Announce Strategic Investment

- $4 million equity investment to advance delivery device R&D for CNS gene therapy portfolio and other company operations - SOUTH PLAINFIELD, N.J. and IRVINE, Calif., May 9, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) and MRI Interventions, Inc. (MRIC) today announced a strategic equity investment, with PTC purchasing $4.0 million in shares of MRI common stock. PTC and MRI have also entered into a supply agreement for MRI's neurosurgical devices for PTC's current and future gene therapy programs. MR...

8
Yahoo FinanceMay 8

PTC Therapeutics to Participate at Upcoming Investor Conferences

SOUTH PLAINFIELD, N.J., May 8, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) today announced that management will present a company update at the following conferences: Bank of America Merrill Lynch Healthcare Conference Tuesday, May 14th at 1:40 p.m. PT RBC Capital Markets Healthcare Conference Tuesday, May 21st at 2:05 p.m. ET The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be...

1

Earnings

-$1.29
-$0.85
-$0.41
$0.03
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.